BOSTON (AP) - Massachusetts is getting more than $2.1 million to settle claims that British drug maker Glaxo-Smith-Kline LLC deceptively promoted the diabetes drug Avandia.
The payment is part of a $90 million settlement between Glaxo-Smith-Kline and attorney generals from 38 different states.
Attorney General Martha Coakley's office says the Massachusetts share of the settlement will mostly fund programs to lower health care costs for residents, combat unlawful marketing practices in the health care market or benefit consumers.
Attorney generals say Glaxo-Smith-Kline misrepresented Avandia's cardiovascular risks and safety profile.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.